• Something wrong with this record ?

Embryonic Vascular Dysgenesis: The Origin of Proximal Femoral Focal Deficiency

DR. Hootnick, N. Vargesson, JA. Horton, J. Chomiak

. 2025 ; 117 (4) : e2465. [pub] -

Language English Country United States

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc25016215

BACKGROUND: Proximal Femoral Focal Deficiency (PFFD) is the most proximal manifestation of a syndrome involving Congenitally Shortened lower Limbs (CSL), which also affects the fibula and midline metatarsals. This pattern of congenital human long bone deficiencies corresponds, in a time dependent manner, to the failed ingrowth pathways of new blood vessels of the growing embryonic limb. The distal femoral condyles are, in contrast, served by an alternative vascular supply from around the knee joint, and so remain resistant to the CSL deficiency. AIM: We hypothesize that embryonic vascular dysgenesis causes PFFD, as well as the cardinal features of the Femoral, Fibular and midline Metatarsal deficiencies (FFM) syndrome. RESULTS: Arteriography of CSL with PFFD reveals diminution or failed formation of the Femoral Artery (FA), which corresponds to downstream skeletal reductions. It may also reveal preservation of the primitive Axial Artery (AA) of the embryonic limb. The combination of missing and retained primitive vessels inform the time, place, and nature of the etiologic vascular events. This suggests that PFFD is the visible expression of a normally prefigured cartilaginous scaffold of the femur, which develops in conformity with the available pattern of blood vessels present. The teratogen thalidomide, known to affect the forming embryonic vasculature, also produces PFFD indistinguishable from the naturally occurring entity. CONCLUSION: The entire spectrum of PFFD, including phocomelia, fibular, and metatarsal dystrophisms, should thus be regarded as downstream skeletal results of embryonic arterial dysgeneses.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016215
003      
CZ-PrNML
005      
20250731091617.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/bdr2.2465 $2 doi
035    __
$a (PubMed)40191900
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hootnick, David R $u Department of Orthopedic Surgery, Department of Cell & Developmental Biology, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA $1 https://orcid.org/0000000335401931
245    10
$a Embryonic Vascular Dysgenesis: The Origin of Proximal Femoral Focal Deficiency / $c DR. Hootnick, N. Vargesson, JA. Horton, J. Chomiak
520    9_
$a BACKGROUND: Proximal Femoral Focal Deficiency (PFFD) is the most proximal manifestation of a syndrome involving Congenitally Shortened lower Limbs (CSL), which also affects the fibula and midline metatarsals. This pattern of congenital human long bone deficiencies corresponds, in a time dependent manner, to the failed ingrowth pathways of new blood vessels of the growing embryonic limb. The distal femoral condyles are, in contrast, served by an alternative vascular supply from around the knee joint, and so remain resistant to the CSL deficiency. AIM: We hypothesize that embryonic vascular dysgenesis causes PFFD, as well as the cardinal features of the Femoral, Fibular and midline Metatarsal deficiencies (FFM) syndrome. RESULTS: Arteriography of CSL with PFFD reveals diminution or failed formation of the Femoral Artery (FA), which corresponds to downstream skeletal reductions. It may also reveal preservation of the primitive Axial Artery (AA) of the embryonic limb. The combination of missing and retained primitive vessels inform the time, place, and nature of the etiologic vascular events. This suggests that PFFD is the visible expression of a normally prefigured cartilaginous scaffold of the femur, which develops in conformity with the available pattern of blood vessels present. The teratogen thalidomide, known to affect the forming embryonic vasculature, also produces PFFD indistinguishable from the naturally occurring entity. CONCLUSION: The entire spectrum of PFFD, including phocomelia, fibular, and metatarsal dystrophisms, should thus be regarded as downstream skeletal results of embryonic arterial dysgeneses.
650    _2
$a lidé $7 D006801
650    12
$a femur $x abnormality $x krevní zásobení $x embryologie $7 D005269
650    12
$a arteria femoralis $x abnormality $x embryologie $7 D005263
650    12
$a vrozené deformity dolní končetiny $x embryologie $7 D038061
650    _2
$a metatarzální kosti $x abnormality $7 D008682
650    _2
$a fibula $x abnormality $x krevní zásobení $7 D005360
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vargesson, Neil $u School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK $1 https://orcid.org/000000018027114X
700    1_
$a Horton, Jason A $u Department of Neuroscience & Physiology, Department of Radiation Oncology, Department of Cell & Developmental Biology, SUNY Upstate Medical University, Syracuse, New York, USA $1 https://orcid.org/0000000333965063
700    1_
$a Chomiak, Jiri $u Department of Orthopaedics, Institute for Postgraduate Medical Education and First Faculty of Medicine, Charles University and Teaching Hospital Na Bulovce, Prague, Czech Republic $1 https://orcid.org/0000000180959016 $7 xx0060351
773    0_
$w MED00208301 $t Birth defects research $x 2472-1727 $g Roč. 117, č. 4 (2025), s. e2465
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40191900 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091612 $b ABA008
999    __
$a ok $b bmc $g 2366807 $s 1253340
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 117 $c 4 $d e2465 $e - $i 2472-1727 $m Birth defects research $n Birth Defects Res $x MED00208301
LZP    __
$a Pubmed-20250708
Back

Find record

Citation metrics

Archiving options